Evidence method
Sequential · gp.financial.deposits
4.94% · CORE · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
SBFG · Mar 31, 2026
SB FINANCIAL GROUP, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001213900-26-053234Bank
Evidence method
Yoy · gp.fundamentals.net_income
99.07% · CORE · VALID
Evidence method
Level · gp.fundamentals.cash
$126.3M · CORE · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History56 statesSelf-history eligible
Sep 30, 20206/6 normalizedLevel 3Dec 31, 20206/6 normalizedLevel 3Mar 31, 20216/6 normalizedLevel 3Jun 30, 20216/6 normalizedLevel 3Sep 30, 20216/6 normalizedLevel 3Dec 31, 20216/6 normalizedLevel 3Mar 31, 20226/6 normalizedLevel 3Jun 30, 20226/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/6 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20235/5 normalizedLevel 3Dec 31, 20234/4 normalizedLevel 3Sep 30, 20243/3 normalizedLevel 3Dec 31, 20243/3 normalizedLevel 3Sep 30, 20253/3 normalizedLevel 3Dec 31, 20253/3 normalizedLevel 3Mar 31, 20263/3 normalizedLevel 3Jun 30, 20263/3 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 3.54%
- Current
- 4.94%
- Delta
- 1.40%
- Previous
- 21.83%
- Current
- 99.07%
- Delta
- 77.24%
- Previous
- $71.5M
- Current
- $126.3M
- Delta
- $54.8M
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.